Bank of America downgraded LENZ Therapeutics' stock on September 2, 2026, citing slow commercial launch.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America downgraded LENZ Therapeutics' stock on September 2, 2026, citing slow commercial launch.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bank of America
American multinational banking and financial services corporation